Gingivitis

Earn CME/CE in your profession:


Continuing Education Activity

Gingivitis is an inflammatory condition of the gingival tissue most commonly caused by bacterial infection. Unlike periodontitis, there is no attachment loss and therefore no migration of the junctional epithelium. This activity describes the evaluation and management of gingivitis and highlights the role of the interprofessional team in managing patients with this condition.

Objectives:

  • Describe the etiology and pathogenesis of gingivitis.
  • Identify the clinical signs and symptoms of gingivitis.
  • Review the treatment options for patients with gingivitis.
  • Outline the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients affected by gingivitis.

Introduction

Gingivitis is an inflammatory condition of the gingival tissue, most commonly caused by bacterial infection. Unlike periodontitis, there is no attachment loss and therefore no migration of the junctional epithelium. The condition is restricted to the soft-tissue area of the gingival epithelium and connective tissue [1]. Among all the periodontal diseases, gingivitis is considered to be the commonest. There are various forms of gingivitis based on clinical appearance, duration of infection, severity, and etiology. However, the chronic form of gingivitis that is caused by plaque is considered to be the most frequent variant. Clinically, the gingival tissues are characterized by swelling, redness, tenderness, a shiny surface, and bleeding upon gentle probing. Gingivitis seldom generates spontaneous bleeding and is commonly painless, therefore many patients do not recognize the disease and fail to seek attention [2].

Etiology

Gingivitis is caused by the microbial plaque deposits located in or close to the gingival sulcus. The microorganisms more strongly associated with the etiology of gingivitis include species of Streptococcus, Fusobacterium, Actinomyces, Veillonella, and Treponema. Bacteroides, Capnocytophaga, and Eikenella are also potentially linked to the etiology of the disease. There may be other local or systemic etiologic factors that intensify plaque deposition or the vulnerability of the tissue to the microbial attack [3].

Based on the etiology, gingivitis can be classified into different types.

Plaque Induced Gingivitis

This is the most common cause of gingivitis. Plaque is a thin film that forms on the tooth surface due to poor oral hygiene. If not regularly removed, it can harden up and form calculus. As plaque harbors a large number of bacteria, inflammation can occur in the gingival tissue.

Some local factors can contribute to the formation of plaque, such as crowding of teeth due to which plaque removal becomes difficult. As misaligned teeth often require orthodontic correction, cleaning difficulty increases accumulating more plaque. Furthermore, a dental prosthesis that does not have an adequate fit or is not properly finished can also act as a nidus for plaque accumulation.

In children, tooth eruption is frequently associated with gingivitis as plaque accumulation tends to increase in the area where primary teeth are exfoliating, and permanent teeth are erupting as oral hygiene may be difficult to be maintained in these areas. This is referred to as eruption gingivitis.

Nutritional Gingivitis

This may occur due to a deficiency of vitamin C. It has been found that a modern lifestyle with the intake of an increased amount of refined carbohydrates and an increased ratio of omega-6 to omega-3 fatty acids can promote the inflammatory process [4]. The mechanism by which carbohydrates with a high glycemic index promote the inflammatory process is through activation of NFkB and oxidative stress [5] [6].

Hormonal Gingivitis

During pregnancy, there are not only changes in hormone levels but also a greater predisposition to dilating blood vessels. These factors contribute to an exaggerated inflammatory response by the gingival tissues even to a minor quantity of plaque accumulation. In fact, it has been suggested that the levels of estrogen determine the severity of gingival inflammation created against the biofilm at the gingival margin [7] [8].

The hormonal alterations that occurred during puberty influence how the gingival tissue reacts to plaque accumulation causing what is known as puberty gingivitis. It has been found that in the cytoplasm of the cells of the gingiva, receptors for both estrogens and testosterone that have a high affinity for these hormones are present. The receptors for estrogen are specifically present in the basal and spinous layers of the epithelium. In the connective tissue, such receptors are found in the fibroblasts and endothelial cells of small vessels. Therefore, the gingiva is an easy target organ for these steroid hormones resulting in gingivitis. It has been observed that during adolescence, gingivitis appears earlier in girls (eleven to thirteen years) than in boys (thirteen to fourteen years) [9].

Drug-Induced Gingivitis

Various drugs used for systemic conditions can cause gingivitis as a side effect such as phenytoin (used for epileptic seizures), calcium channel blockers (used for angina, high blood pressure), anticoagulants, and fibrinolytic agents, oral contraceptive agents, protease inhibitors, vitamin A and analogs. The mechanism behind this gingival inflammation is thought to be the ability of the metabolites of these drugs to induce the proliferation of fibroblasts. An imbalance between the synthesis and the degradation of the extracellular matrix leads to the accumulation of immature proteins in the extracellular matrix, particularly collagen. This, in turn, results in gingivitis [10].

Apart from the already mentioned, various risk and influencing factors can contribute to the development of gingivitis. These include smoking and tobacco chewing, systemic conditions, genetic factors (hereditary gingival fibromatosis), and local conditions (dry mouth, crowded teeth).

Epidemiology

Gingivitis is the commonest of periodontal diseases. It is more prevalent in males as compared to females since it has been found that females tend to follow better oral care regimes. It is commonly seen in children and adults. Studies have found gingivitis to be more prevalent in people with low socioeconomic status as people with high socioeconomic status tend to show a more positive attitude towards the maintenance of oral hygiene. Also, they have better access to health care options. Studies reveal that gingivitis is more prevalent in pregnant women as compared to non-pregnant women. Moreover, more severe forms of gingivitis have been more often seen in pregnant women [11].

The most frequently seen types of gingivitis are plaque-induced, hormonal, acute ulcerative necrotizing, drug-induced, or spontaneously presenting hyperplastic gingivitis. Categorically, the more predominant form of gingivitis is plaque-induced. In fact, this type accounts for far more cases than all other variants combined [12].

Pathophysiology

Periodontal disease undergoes four different stages that were first explained by Page and Schroeder in 1976 [13]. Pathophysiologically, gingivitis has been divided into initial, early, and established stages, and periodontitis has been indicated as the advanced stage.

Initial Lesion

This stage is characterized by an acute exudative inflammatory response, a raised gingival fluid flow, and the migration of neutrophils from the blood vessel of the subgingival plexus located in the gingival connective tissue to the gingival sulcus. An alteration of the matrix of the connective tissue located next to vessels results in the accumulation of fibrin in the area. The initial lesion is seen within four days of the initiation of plaque accumulation. There is a destruction of collagen caused by collagenase and other enzymes secreted by the neutrophils. About 5% to 10% of the connective tissue is occupied by the inflammatory infiltrate in this stage [12].

Early Lesion

The early lesion is consistent with delayed hypersensitivity. It usually appears after one week from the beginning of plaque deposition. In this stage, the clinical signs of gingivitis, such as redness and bleeding from the gingiva start appearing. The inflammatory cells that predominate in this lesion are lymphocytes accounting for 75% of the total, and macrophages. A small number of plasma cells are also seen. Along with the inflammatory infiltration that occupies 5% to 15% of the connective tissue of the gingival margin, there is loss of collagen in the affected area that reaches 60% to 70%. Furthermore, the local fibroblasts undergo a series of pathological changes, and the gingival fluid flow and the number of leukocytes migrating to the region continue to increase. Neutrophils and mononuclear cells are also increased in the junctional epithelium. The duration of the early lesion has not yet been determined, it can remain for more time than previously expected [12].

Established Lesion

There is increased collagenolytic activity in this stage along with a rise in the number of macrophages, plasma cells, T and B lymphocytes. However, the predominant cells are plasma cells and B lymphocytes. In this stage, a small gingival pocket lined with a pocket epithelium is created. The lesion exhibits a high degree of organization. It has been suggested that the severity of gingivitis correlates with a growth in the B cells and plasma cells population, and a decrease in the number of T cells.

An established lesion may follow two paths, it can either remain stable for months or years; or progress to a more destructive lesion, which appears to be related to a change in the microbial flora or infection of the gingiva. This stage has shown to be reversible after an effective periodontal therapy that results in an increase in the number of microorganisms associated with periodontal health that directly correlates with a reduction in the plasma cells and lymphocytes [12].

Advanced Lesion

This stage is a transition to periodontitis. It is characterized by attachment loss that is irreversible. The inflammatory changes and the bacterial infection starts affecting the supporting tissues of the teeth and the surrounding structures such as gingival, periodontal ligament, and alveolar bone resulting in their destruction and may eventually result in tooth loss [14][15].

History and Physical

Healthy gingival tissue looks pink or pigmented in dark-skinned patients, firm, with no signs of redness or swelling, and with no bleeding after gently passing a periodontal probe along the gingival crevice. On periodontal probing, healthy gingiva shows less than 3 mm crevice and there is no bone loss on x-rays.In many instances, gingivitis may go unnoticed by the patient as the disease may exist and progress without any symptoms. When symptomatic, the patient usually gives a history of bleeding from the gingiva while brushing, flossing, and sometimes eating particularly hard food, along with halitosis that does not resolve even after performing oral hygiene. Physical examination of the oral cavity will reveal the presence of an inflamed and tender gingiva that usually bleeds on gentle probing. The gingival margins that show a knife-edge appearance and the gingival tissue with stippled aspect found in healthy gingiva are replaced by a more rounded and shiny aspect. Significant plaque and calculus deposits are usually seen.

In chronic gingivitis, the size of the gingival tissue may be increased towards incisal due to the edema or hyperplasia resulting in probing depths more than 3 mm; however, no attachment loss has occurred. These are known as false pockets.

The gingival swelling can be graded into four types.

  • Grade 0: No signs of gingival swelling.
  • Grade I: Swelling that is confined to the interdental papilla region.
  • Grade II: Swelling involving both the interdental papilla and the marginal gingiva.
  • Grade III: Swelling that covers three-fourths or more of the crown structure.

The Gingival Index (GI)

The purpose of the gingival index is to indicate the quality of the gingival tissue, differentiating the severity of the lesion, and the location of the alteration concerning the four areas that form the perimeter of the marginal gingiva. The criteria included in the index are only related to qualitative changes in the gingiva. A score from 0 to 3 is given to each area of the tooth (mesial, distal, vestibular, palatine, or lingual), this is the GI for the area. The GI score per tooth is achieved by adding the scores from the four areas and then dividing this number by four. The GI for the subject is obtained by adding the indices of each tooth and dividing them into the number of teeth that were examined [16].

Criteria for the gingival index system

0: Normal gingiva1: Mild inflammation – a slight color change, slight edema. No bleeding on probing.2: Moderate inflammation – redness, edema, and glazing. Bleeding on probing.3: Severe inflammation – marked redness and edema. Ulceration. Tendency to spontaneous bleeding [16].

Classification of gingivitis

In the latest International Workshop for a Classification of Periodontal Diseases and Conditions in 2017, gingival diseases have been classified as follow:

Gingivitis - dental biofilm-induced

  1. Associated with dental biofilm alone
  2. Mediated by systemic or local risk factors
  3. Drug-influenced gingival enlargement

Gingival diseases non-dental biofilm induced

  1. Genetic/ developmental disorders
  2. Specific infections
  3. Inflammatory and immune conditions
  4. Reactive processes
  5. Neoplasms
  6. Endocrine, nutritional, and metabolic diseases
  7. Traumatic lesions
  8. Gingival pigmentation [17]

Evaluation

As gingivitis is a soft tissue disease, radiographic evaluation is not usually necessary; however, it may be of help for differentiating gingivitis from periodontitis in some cases. Lab investigations are also routinely not required.

Treatment / Management

The prime objective of treating gingivitis is to reduce inflammation. This is achieved by the use of different instruments to remove dental plaque deposits [18]. Gingivitis, in its initial stages, can be easily managed if the patient starts following oral hygiene protocol, which includes regular tooth brushing with an appropriate technique and interproximal hygiene, such as dental flossing, or the use of interproximal brushes. The removal of plaque and calculus is also professionally achieved by scaling and root planning according to the severity of the condition.

If it is a drug-induced gingival overgrowth, the physician can change the medication to improve the outcome of treatment of the condition. If it is due to nutritional deficiency, supplements can be prescribed. Medications in the form of antiseptic mouthwash that contains chlorhexidine can also be prescribed in conjunction with the mechanical removal of plaque. It has been suggested that the use of chlorhexidine mouthwashes in addition to the usual toothbrushing and interproximal cleaning leads to a significant decrease in the build-up of dental biofilm. The concentration of the chlorhexidine rinse does not affect its effectiveness [19].

There are studies on the effect of medicinal or herbal plants on the management of gingivitis. The mechanism of action of these plants on gingivitis is due to their anti-inflammatory property. Such medicinal plants include pomegranate, tea, and chamomile. The flavonoids and tannins present in these plants are potent anti-inflammatory and astringent phytochemicals. Therefore, they can resolve both gingival bleeding and inflammation [20]. Some studies proved that there is a synergistic effect when the herbal plants are prescribed along with conventional mechanical procedures of plaque removal, such as scaling [21].

Differential Diagnosis

Gingivitis can be differentiated from periodontitis by the attachment loss undergone in the latter that can be clinically noticed during periodontal probing [22]. They can also be differentiated histologically and radiographically.

Prognosis

Gingivitis, if identified and treated, can easily be resolved as the condition is reversible and the altered tissues can return to normal once the dental biofilm has been removed. If gingivitis progress to periodontitis, connective tissue attachment loss, and bone destruction will occur, which may ultimately result in tooth loss.

Complications

The most common complication or sequelae of chronic gingivitis is the progression of the inflammation towards the underlying tissue and bone, resulting in periodontitis. The ultimate consequence of such an event is tooth loss. Gingivitis is a precursor of periodontitis. However, gingivitis does not always progress to periodontitis.

Deterrence and Patient Education

The patient should be educated on the importance of maintaining good oral hygiene, which can prevent the formation of plaque and, thus, gingivitis. A correct brushing technique according to individual needs, frequency of brushing, and use of interproximal hygiene must be taught. Furthermore, the importance of regular dental visits should be emphasized. Finally, the use of mouthwash may also be advised [23][24].

Enhancing Healthcare Team Outcomes

To improve the treatment outcome of gingivitis, an interprofessional approach is required to identify the causes of the disease and to intervene at an early stage. Also, a thorough knowledge of the epidemiological pattern is required for planning the public-health services as plaque-induced gingivitis can be seen at any age of the dentate population. Periodontal disease is not just limited to the destruction of the periodontium, it affects general systemic health too. Thus, both dentists and physicians must be aware of the close link between periodontal disease and systemic diseases, such as diabetes mellitus, cardiovascular diseases, and preterm birth or low birth weight (PLBW) [25][26][27].


Details

Author

Manu Rathee

Editor:

Prachi Jain

Updated:

3/27/2023 8:38:26 PM

Looking for an easier read?

Click here for a simplified version

References


[1]

Marchesan JT, Girnary MS, Moss K, Monaghan ET, Egnatz GJ, Jiao Y, Zhang S, Beck J, Swanson KV. Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics. Periodontology 2000. 2020 Feb:82(1):93-114. doi: 10.1111/prd.12269. Epub     [PubMed PMID: 31850638]


[2]

Trombelli L, Farina R, Silva CO, Tatakis DN. Plaque-induced gingivitis: Case definition and diagnostic considerations. Journal of periodontology. 2018 Jun:89 Suppl 1():S46-S73. doi: 10.1002/JPER.17-0576. Epub     [PubMed PMID: 29926936]

Level 3 (low-level) evidence

[3]

Trombelli L, Farina R, Silva CO, Tatakis DN. Plaque-induced gingivitis: Case definition and diagnostic considerations. Journal of clinical periodontology. 2018 Jun:45 Suppl 20():S44-S67. doi: 10.1111/jcpe.12939. Epub     [PubMed PMID: 29926492]

Level 3 (low-level) evidence

[4]

Bosma-den Boer MM, van Wetten ML, Pruimboom L. Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering. Nutrition & metabolism. 2012 Apr 17:9(1):32. doi: 10.1186/1743-7075-9-32. Epub 2012 Apr 17     [PubMed PMID: 22510431]


[5]

Dickinson S, Hancock DP, Petocz P, Ceriello A, Brand-Miller J. High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. The American journal of clinical nutrition. 2008 May:87(5):1188-93     [PubMed PMID: 18469238]


[6]

Hu Y, Block G, Norkus EP, Morrow JD, Dietrich M, Hudes M. Relations of glycemic index and glycemic load with plasma oxidative stress markers. The American journal of clinical nutrition. 2006 Jul:84(1):70-6; quiz 266-7     [PubMed PMID: 16825683]


[7]

Gürsoy M, Gürsoy UK, Sorsa T, Pajukanta R, Könönen E. High salivary estrogen and risk of developing pregnancy gingivitis. Journal of periodontology. 2013 Sep:84(9):1281-9. doi: 10.1902/jop.2012.120512. Epub 2012 Dec 13     [PubMed PMID: 23237582]


[8]

Bilińska M, Sokalski J. [Pregnancy gingivitis and tumor gravidarum]. Ginekologia polska. 2016:87(4):310-3. doi: 10.17772/gp/62354. Epub     [PubMed PMID: 27321105]


[9]

Nakagawa S, Fujii H, Machida Y, Okuda K. A longitudinal study from prepuberty to puberty of gingivitis. Correlation between the occurrence of Prevotella intermedia and sex hormones. Journal of clinical periodontology. 1994 Nov:21(10):658-65     [PubMed PMID: 7852609]


[10]

Tungare S, Paranjpe AG. Drug Induced Gingival Overgrowth. StatPearls. 2023 Jan:():     [PubMed PMID: 30860753]


[11]

Kashetty M, Kumbhar S, Patil S, Patil P. Oral hygiene status, gingival status, periodontal status, and treatment needs among pregnant and nonpregnant women: A comparative study. Journal of Indian Society of Periodontology. 2018 Mar-Apr:22(2):164-170. doi: 10.4103/jisp.jisp_319_17. Epub     [PubMed PMID: 29769772]

Level 2 (mid-level) evidence

[12]

Page RC. Gingivitis. Journal of clinical periodontology. 1986 May:13(5):345-59     [PubMed PMID: 3522644]


[13]

Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Laboratory investigation; a journal of technical methods and pathology. 1976 Mar:34(3):235-49     [PubMed PMID: 765622]


[14]

Bosshardt DD, Selvig KA. Dental cementum: the dynamic tissue covering of the root. Periodontology 2000. 1997 Feb:13():41-75     [PubMed PMID: 9567923]


[15]

Syndergaard B, Al-Sabbagh M, Kryscio RJ, Xi J, Ding X, Ebersole JL, Miller CS. Salivary biomarkers associated with gingivitis and response to therapy. Journal of periodontology. 2014 Aug:85(8):e295-303. doi: 10.1902/jop.2014.130696. Epub 2014 Feb 6     [PubMed PMID: 24502627]


[16]

Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of periodontology. 1967 Nov-Dec:38(6):Suppl:610-6     [PubMed PMID: 5237684]


[17]

Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. Journal of periodontology. 2018 Jun:89 Suppl 1():S1-S8. doi: 10.1002/JPER.18-0157. Epub     [PubMed PMID: 29926946]


[18]

Pozo P, Valenzuela MA, Melej C, Zaldívar M, Puente J, Martínez B, Gamonal J. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. Journal of periodontal research. 2005 Jun:40(3):199-207     [PubMed PMID: 15853964]


[19]

James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A, Whelton H, Riley P. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. The Cochrane database of systematic reviews. 2017 Mar 31:3(3):CD008676. doi: 10.1002/14651858.CD008676.pub2. Epub 2017 Mar 31     [PubMed PMID: 28362061]

Level 1 (high-level) evidence

[20]

Safiaghdam H, Oveissi V, Bahramsoltani R, Farzaei MH, Rahimi R. Medicinal plants for gingivitis: a review of clinical trials. Iranian journal of basic medical sciences. 2018 Oct:21(10):978-991. doi: 10.22038/IJBMS.2018.31997.7690. Epub     [PubMed PMID: 30524670]


[21]

Ajmera N, Chatterjee A, Goyal V. Aloe vera: It's effect on gingivitis. Journal of Indian Society of Periodontology. 2013 Jul:17(4):435-8. doi: 10.4103/0972-124X.118312. Epub     [PubMed PMID: 24174720]


[22]

Dietrich T, Kaye EK, Nunn ME, Van Dyke T, Garcia RI. Gingivitis susceptibility and its relation to periodontitis in men. Journal of dental research. 2006 Dec:85(12):1134-7     [PubMed PMID: 17122168]


[23]

Woelber JP, Bremer K, Vach K, König D, Hellwig E, Ratka-Krüger P, Al-Ahmad A, Tennert C. An oral health optimized diet can reduce gingival and periodontal inflammation in humans - a randomized controlled pilot study. BMC oral health. 2016 Jul 26:17(1):28. doi: 10.1186/s12903-016-0257-1. Epub 2016 Jul 26     [PubMed PMID: 27460471]

Level 3 (low-level) evidence

[24]

Díaz Sánchez RM, Castillo-Dalí G, Fernández-Olavarría A, Mosquera-Pérez R, Delgado-Muñoz JM, Gutiérrez-Pérez JL, Torres-Lagares D. A Prospective, Double-Blind, Randomized, Controlled Clinical Trial in the Gingivitis Prevention with an Oligomeric Proanthocyanidin Nutritional Supplement. Mediators of inflammation. 2017:2017():7460780. doi: 10.1155/2017/7460780. Epub 2017 Dec 10     [PubMed PMID: 29375198]

Level 1 (high-level) evidence

[25]

Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, Taylor R. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012 Jan:55(1):21-31. doi: 10.1007/s00125-011-2342-y. Epub 2011 Nov 6     [PubMed PMID: 22057194]


[26]

Dhadse P, Gattani D, Mishra R. The link between periodontal disease and cardiovascular disease: How far we have come in last two decades ? Journal of Indian Society of Periodontology. 2010 Jul:14(3):148-54. doi: 10.4103/0972-124X.75908. Epub     [PubMed PMID: 21760667]


[27]

Haerian-Ardakani A, Eslami Z, Rashidi-Meibodi F, Haerian A, Dallalnejad P, Shekari M, Moein Taghavi A, Akbari S. Relationship between maternal periodontal disease and low birth weight babies. Iranian journal of reproductive medicine. 2013 Aug:11(8):625-30     [PubMed PMID: 24639799]